Models & animals
May we use animals to test new fertility tech?
Open access · cc by · source: Europe PMC
New ARTs have often been introduced by trial and error on women and children; the authors ask whether that aim is weighty enough to justify animal work, and separate that question from 3Rs refinement.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
ART papers ask whether preventing trial-and-error on women and children is a weighty enough aim to justify animal work, a question separated from 3Rs refinement — not the same issue as psychiatric-model validity.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
ART papers ask whether preventing trial-and-error on women and children is a weighty enough aim to justify animal work, a question separated from 3Rs refinement — not the same issue as psychiatric-model validity.
- Supports · Should animal models copy the DSM?
Study at a glance
- Design
- Other — Ethical analysis separating the moral weight of ART aims from 3Rs/animal-welfare constraints
- N
- Normative ethics paper; not an empirical sample
- Population
- Preclinical animal research proposed to test new assisted reproductive technologies
- Outcome
- Whether helping people have genetically related children justifies animal use, kept distinct from refinement
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
May we use animals to test new fertility tech?
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
Historical problem?
trial and error basis, thus exposing women and their future children to potential harms of procedures that are possibly risky and of unclear benefit (Dondo
Responsible path?
preclinical efficacy and safety research part of the responsible introduction of new assisted reproductive technologies (ARTs). In order to achieve this, t
Key findings
MAR does serve a morally weighty aim, but that does not automatically license any animal use. Two arguments must be kept apart: the importance of the human aim, and what may be done to animals. Better-translating species raise the welfare stakes.
Methodology
They reconstruct the call for preclinical efficacy and safety research before new ARTs, note EU talk of phasing out animal research, distinguish the moral weight of helping people have genetically related children from welfare/3Rs issues, and discuss translational use of non-human primates.
Limitations
This is normative ethics, not a new embryo-lab study. It does not pick a single ART to ban or approve.
Related papers in this topic
Same topic cluster — not a recommendation engine.